NO128897B - - Google Patents
Download PDFInfo
- Publication number
- NO128897B NO128897B NO92569A NO92569A NO128897B NO 128897 B NO128897 B NO 128897B NO 92569 A NO92569 A NO 92569A NO 92569 A NO92569 A NO 92569A NO 128897 B NO128897 B NO 128897B
- Authority
- NO
- Norway
- Prior art keywords
- lactic acid
- carbamide
- skin
- amount
- weight
- Prior art date
Links
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 claims description 38
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 38
- 239000003795 chemical substances by application Substances 0.000 claims description 23
- 235000013877 carbamide Nutrition 0.000 claims description 19
- 239000004202 carbamide Substances 0.000 claims description 19
- 239000004310 lactic acid Substances 0.000 claims description 19
- 235000014655 lactic acid Nutrition 0.000 claims description 19
- 150000002632 lipids Chemical class 0.000 claims description 15
- 239000002537 cosmetic Substances 0.000 claims description 12
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 claims description 3
- 229960003237 betaine Drugs 0.000 claims description 2
- 239000003581 cosmetic carrier Substances 0.000 claims description 2
- 239000007864 aqueous solution Substances 0.000 claims 2
- 239000000243 solution Substances 0.000 claims 2
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 claims 1
- 239000008177 pharmaceutical agent Substances 0.000 claims 1
- 210000003491 skin Anatomy 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 210000000434 stratum corneum Anatomy 0.000 description 8
- 239000003995 emulsifying agent Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 238000002360 preparation method Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 5
- 206010000496 acne Diseases 0.000 description 4
- 239000013543 active substance Substances 0.000 description 4
- 230000035515 penetration Effects 0.000 description 4
- 239000000825 pharmaceutical preparation Substances 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 208000002874 Acne Vulgaris Diseases 0.000 description 3
- 239000002253 acid Substances 0.000 description 3
- -1 steroid compounds Chemical class 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 230000002195 synergetic effect Effects 0.000 description 3
- 229930182843 D-Lactic acid Natural products 0.000 description 2
- JVTAAEKCZFNVCJ-UWTATZPHSA-N D-lactic acid Chemical compound C[C@@H](O)C(O)=O JVTAAEKCZFNVCJ-UWTATZPHSA-N 0.000 description 2
- 206010040844 Skin exfoliation Diseases 0.000 description 2
- 230000009918 complex formation Effects 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 230000035618 desquamation Effects 0.000 description 2
- JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
- 239000007764 o/w emulsion Substances 0.000 description 2
- 230000001737 promoting effect Effects 0.000 description 2
- 208000017520 skin disease Diseases 0.000 description 2
- FUFLCEKSBBHCMO-UHFFFAOYSA-N 11-dehydrocorticosterone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)C(=O)CO)C4C3CCC2=C1 FUFLCEKSBBHCMO-UHFFFAOYSA-N 0.000 description 1
- MFYSYFVPBJMHGN-ZPOLXVRWSA-N Cortisone Chemical compound O=C1CC[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 MFYSYFVPBJMHGN-ZPOLXVRWSA-N 0.000 description 1
- MFYSYFVPBJMHGN-UHFFFAOYSA-N Cortisone Natural products O=C1CCC2(C)C3C(=O)CC(C)(C(CC4)(O)C(=O)CO)C4C3CCC2=C1 MFYSYFVPBJMHGN-UHFFFAOYSA-N 0.000 description 1
- 206010012438 Dermatitis atopic Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000000129 anionic group Chemical group 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- 208000010668 atopic eczema Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 229960004544 cortisone Drugs 0.000 description 1
- 229940022769 d- lactic acid Drugs 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229960001347 fluocinolone acetonide Drugs 0.000 description 1
- FEBLZLNTKCEFIT-VSXGLTOVSA-N fluocinolone acetonide Chemical compound C1([C@@H](F)C2)=CC(=O)C=C[C@]1(C)[C@]1(F)[C@@H]2[C@@H]2C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]2(C)C[C@@H]1O FEBLZLNTKCEFIT-VSXGLTOVSA-N 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 229960000890 hydrocortisone Drugs 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 206010021198 ichthyosis Diseases 0.000 description 1
- 230000003020 moisturizing effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- 150000003839 salts Chemical class 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 229960002117 triamcinolone acetonide Drugs 0.000 description 1
- YNDXUCZADRHECN-JNQJZLCISA-N triamcinolone acetonide Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@H]3OC(C)(C)O[C@@]3(C(=O)CO)[C@@]1(C)C[C@@H]2O YNDXUCZADRHECN-JNQJZLCISA-N 0.000 description 1
- 239000007762 w/o emulsion Substances 0.000 description 1
- 210000002268 wool Anatomy 0.000 description 1
Landscapes
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE02977/68A SE325667B (ru) | 1968-03-06 | 1968-03-06 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO128897B true NO128897B (ru) | 1974-01-28 |
Family
ID=20261130
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO92569A NO128897B (ru) | 1968-03-06 | 1969-03-05 |
Country Status (2)
| Country | Link |
|---|---|
| IT (1) | IT988510B (ru) |
| NO (1) | NO128897B (ru) |
-
1969
- 1969-03-05 NO NO92569A patent/NO128897B/no unknown
- 1969-03-05 IT IT1368869A patent/IT988510B/it active
Also Published As
| Publication number | Publication date |
|---|---|
| IT988510B (it) | 1975-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60127861T2 (de) | Öl-in-wasser-emulsionszusammensetzung und verfahren zu ihrer herstellung | |
| RU2545691C2 (ru) | Композиции для ухода за кожей | |
| DE1911144A1 (de) | Hauptbehandlungsmittel und Traegerstoff fuer Hautbehandlungsmittel | |
| Dahl et al. | 12% lactate lotion for the treatment of xerosis: a double-blind clinical evaluation | |
| US4593046A (en) | Method of reducing skin irritation from benzoyl peroxide | |
| DE69500315T2 (de) | Kosmetische oder dermatologische Wasser-in-Öl Emulsion mit hohem Gehalt an Hydroxysäuren | |
| JPS59500129A (ja) | 長鎖アルカノ−ル及び酸化防止剤を含有する皮脂抑制性化粧剤 | |
| DE3032462A1 (de) | Praeparate zur anwendung an oder in geweben und/oder fluessigkeiten des menschlichen oder tierischen koerpers | |
| DE68912195T2 (de) | Verwendung von Pyrrolicloncarbonsäurealkylestern zur Herstellung eines Arzneimittels zur Behandlung von Ichtyosis. | |
| ES2138306T3 (es) | Utilizacion del acido ascorbico como agente activo para el tratamiento de la seborrea en una composicion cosmetica y/o dermatologica. | |
| DE2601489C2 (ru) | ||
| DE2818827C2 (de) | Mittel zur Behandlung von Psoriasis | |
| WO2004039454A1 (de) | Formulierungen enthaltend melatonin, ginkgo biloba und biotin | |
| DE2300594C2 (de) | Hautbehandlungsmittel | |
| DE3411225C2 (ru) | ||
| DE1617320C3 (de) | Hautbehandlungsmittel | |
| DE3603859A1 (de) | Abwaschbare topische zubereitung zur therapie der psoriasis | |
| JPS6341411A (ja) | 皮膚外用剤 | |
| DE1201951B (de) | Stabile saure Hauptpflegeemulsion | |
| DE69402259T2 (de) | Zusammensetzungen enthaltend 8-Hydroxychinolin zur Behandlung hyperproliferativer Hautkrankheiten | |
| DE2609575C2 (de) | Kosmetisches Präparat | |
| NO128897B (ru) | ||
| WO2023104843A1 (de) | Topisch applizierbare zubereitung zur verbesserung des hautzustandes | |
| JP4495979B2 (ja) | 頭皮頭髪化粧料 | |
| GB1424598A (en) | Disinfectant |